Pfizer Can't Halt Pay-For-Delay Suit Pending Appeal

Law360, Los Angeles (June 26, 2013, 5:59 PM EDT) -- A federal judge on Wednesday rejected Pfizer Inc.'s attempt to stay the state of West Virginia's allegations that it entered an anti-competitive settlement of a patent dispute with a generic-drug maker pending a petition to the Fourth Circuit to keep the case in federal court.

The decision comes more than a month after U.S. District Judge Robert C. Chambers remanded to a state court the West Virginia attorney general's antitrust suit against Pfizer and generics maker Ranbaxy Laboratories Ltd., which sought to make generic Lipitor. The...
To view the full article, register now.